Universal Beteiligungs und Servicegesellschaft mbH Grows Holdings in STERIS plc $STE

Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in shares of STERIS plc (NYSE:STE) by 13.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,218 shares of the medical equipment provider’s stock after buying an additional 6,613 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in STERIS were worth $14,158,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Allworth Financial LP boosted its stake in STERIS by 7.3% during the 2nd quarter. Allworth Financial LP now owns 661 shares of the medical equipment provider’s stock valued at $159,000 after acquiring an additional 45 shares during the last quarter. Geneos Wealth Management Inc. lifted its position in shares of STERIS by 34.9% during the second quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider’s stock worth $42,000 after purchasing an additional 45 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its position in shares of STERIS by 1.4% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 3,494 shares of the medical equipment provider’s stock worth $865,000 after purchasing an additional 48 shares during the last quarter. Procyon Advisors LLC grew its stake in STERIS by 5.9% in the third quarter. Procyon Advisors LLC now owns 891 shares of the medical equipment provider’s stock worth $220,000 after purchasing an additional 50 shares in the last quarter. Finally, Balefire LLC increased its holdings in STERIS by 5.0% in the third quarter. Balefire LLC now owns 1,128 shares of the medical equipment provider’s stock valued at $279,000 after buying an additional 54 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

STERIS Stock Performance

Shares of STE stock opened at $259.44 on Friday. The company has a quick ratio of 1.63, a current ratio of 2.37 and a debt-to-equity ratio of 0.27. The business has a 50 day moving average of $258.84 and a two-hundred day moving average of $247.46. STERIS plc has a 52 week low of $204.90 and a 52 week high of $269.44. The company has a market cap of $25.46 billion, a P/E ratio of 37.28 and a beta of 1.03.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same period in the prior year, the firm earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th were paid a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Tuesday, November 18th. STERIS’s dividend payout ratio (DPR) is presently 36.21%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Seven analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, STERIS presently has an average rating of “Moderate Buy” and a consensus target price of $273.50.

Insider Activity

In other news, VP John Adam Zangerle sold 15,000 shares of the company’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the completion of the transaction, the vice president owned 33,669 shares in the company, valued at approximately $8,926,998.66. This represents a 30.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Renato Tamaro sold 5,036 shares of the stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the sale, the vice president directly owned 5,695 shares in the company, valued at approximately $1,466,747.25. This trade represents a 46.93% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 25,044 shares of company stock valued at $6,586,218. 1.07% of the stock is currently owned by company insiders.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.